The Economist2d
The bad side-effects of China’s campaign to cut drug costs
These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...
China Digital Times3d
China’s Drug Evaluation Center Curtails Public Data Access Amid Generic Medications Scandal; Whistleblower Deletes Weibo Account
After several doctors voiced concerns about the poor quality of domestically produced generic medications included in China’s national health-care plan—and after online sleuths found numerous examples ...
Vyluma Announces Acceptance of Drug Application for NVK002 by China’s National Medical Products Administration (NMPA)
With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...
This Chinese MIT Physicist Uses AI To Find New Drugs. Next Up: Solar Panels And EV Batteries
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...